There are plenty of high-quality undervalued stocks to buy right now, you just need to know where to look. Here, we highlight ...

Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug ...

On Monday, Chiefs Kingdom received a new update from owner Clark Hunt, who described the situation as having “two great ...

While the Kansas City Chiefs coaches and players are focusing on the football side of things, CEO Clark Hunt is deciding on whether or not the Chiefs will reloc ...

Arrowhead Pharmaceuticals said it earned a $100 million milestone payment from Sarepta Therapeutics. The milestone was triggered when Arrowhead reached the first of two prespecified enrollment targets ...

Arrowhead Pharmaceuticals (ARWR) stock gains as company reassures investors about financial obligations required from Sarepta ...

Sarepta Therapeutics' licensing partner Arrowhead Pharmaceuticals said on Wednesday it expects to receive near-term milestone ...

Shares of Sarepta Therapeutics SRPT surged more than 30% in after-market trading yesterday after the company announced a ...

The Stock Market Just Did Something for the 11th Time Since 1984. History Says It Signals a Big Move in the Next Year. Trevor Jennewine, The Motley Fool Thu, Jul 17, 2025, 4:10 AM6 min read ...

The S&P 500 and Nasdaq reached fresh records on Wednesday, reversing Tuesday's declines. President Trump's tax-and-spending bill squeaked through the Senate and now returns to the House.

Question: Why would anyone pay 37 times earnings for Philip Morris stock when Google stock is available at a more attractive valuation of 19 times earnings? Most wouldn’t—especially when ...